Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Travere Therapeutics Inc’s current trading price is -8.79% away from its 52-week high, while its distance from the 52-week low is 173.63%. The stock’s price range during this period has varied between $5.12 and $15.36. The company, active in the Healthcare sector, saw a trading volume of around 2.93 million for the day, considerably higher average daily volume of 1.44 million observed over the last three months.
Travere Therapeutics Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $15.36 on 09/23/24, while the lowest price during the same period was $5.12 on 04/25/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Travere Therapeutics Inc (TVTX) has experienced a quarterly rise of 70.44% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.07B and boasts a workforce of 380 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.15, with a change in price of +7.46. Similarly, Travere Therapeutics Inc recorded 1,349,779 in trading volume during the last 100 days, posting a change of +113.89%.
How TVTX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for TVTX stands at 26.62. Similarly, the long-term debt-to-equity ratio is also 26.27.
TVTX Stock Stochastic Average
As of today, the raw stochastic average of Travere Therapeutics Inc over the last 50 days is at 81.83%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 77.57%. Further, the company’s Stochastic %K and %D values for the last 20 days were 86.67% and 88.04%, respectively.
TVTX Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a gain of 55.84%.However, over the last six months, we can see a weaker performance of 81.71%. Over the last 30 days, the price of TVTX has fallen by 55.15%. And in the last five days, it has fallen by -7.89%.
